Global Vaccines Administered Orally Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Vaccines Administered Orally Market Research Report 2024
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to Mr Accuracy reports new survey, global Vaccines Administered Orally market is projected to reach US$ 2746.3 million in 2029, increasing from US$ 1874 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaccines Administered Orally market research.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccines Administered Orally market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Human
Animal
Public
Private
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vaccines Administered Orally report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Vaccines Administered Orally market is projected to reach US$ 2746.3 million in 2029, increasing from US$ 1874 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Vaccines Administered Orally market research.
Vaccines Administered Orally have gained attention for their potential to revolutionize immunization. Unlike traditional injection-based vaccines, these oral vaccines are ingested, often through drops or capsules. They offer several advantages, including ease of administration, needle-free delivery, and improved patient compliance, especially in children. Oral vaccines stimulate both local and systemic immune responses, enhancing protection against diseases. Notable examples include the oral polio vaccine and experimental oral cholera vaccines. Despite challenges in formulation and stability, the market for Oral Vaccines is expanding as researchers explore their potential for various infectious diseases. As global health initiatives seek broader vaccine coverage, the convenience and efficacy of orally administered vaccines hold promise for widespread immunization efforts.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccines Administered Orally market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Human
Animal
Segment by Application
Public
Private
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Vaccines Administered Orally report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices